DaltonTx awarded grant to accelerate AI-powered tuberculosis drug discovery
Summary
DaltonTx received a grant from the Gates Foundation to advance AI-powered tuberculosis drug discovery. The company will use its platform to screen Mycobacterium tuberculosis proteins, identify new drug targets, and test model performance with existing biological and chemical data. DaltonTx will also work with Ersilia to publish validated models, datasets, and workflows through the Ersilia Model Hub. The collaboration aims to support researchers in low- and middle-income countries with accessible AI tools and training.
Funding
Amount
-
Total raised
Date
October 15, 2026
Announcement date
Investors
Bill & Melinda Gates Foundation
Lead investors
Company
daltontx.com
Funded company
AskAI Classifications
Sectors
Life Sciences and Pharmaceutical
Life Sciences Analytics
Functions
No functions detected
Linked Companies
DaltonTx
$1M to $5M